智通财经APP获悉，医渡科技(02158)逆市涨超3%，截至发稿，涨2.48%，报6.62港元，成交额8297.33万港元。
消息面上，近日，医渡科技助力哈尔滨医科大学附属肿瘤医院成功实现医渡AI中台+DeepSeek本地化部署。依托国产大模型DeepSeek满血版及医渡“AI医疗大脑”YiduCore，率先打造的AI临床指南助手上线，让诊疗决策有“智”可循。值得一提的是，这是继医渡科技与中南大学湘雅医院、南昌大学第一附属医院、中山大学附属肿瘤医院等一众头部三甲医院合作之后，“YiduCore+DeepSeek”的又一次重要落地和创新突破。
据悉，截至2024年9月30日，医渡科技核心算法引擎YiduCore累计处理和分析超55亿份经授权医疗记录，覆盖超 2800家医院网络，疾病知识图谱基本涵盖所有已知疾病。“通用智能大脑”DeepSeek-R1满血版大模型，拥有6710亿参数规模，在任务性能与泛化能力上表现卓越，可灵活应对各类复杂医疗场景。双脑加持，医生能够更高效精准地完成疾病诊断与治疗规划，制定个性化治疗策略，极大提升诊疗效率与质量。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.